EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Adishwar Rao iD, Venkatesh Ravi iD, Mukunthan Murthi iD, Rahul Chikatimalla iD, Vennela Talla iD, Nihal Nagaraj iD, Gaurav Dhar iD, Neeraj Jolly, Aviral Vij iD

Circulation: Arrhythmia and Electrophysiology · 2026

DOI: 10.1161/circep.126.015245 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2026. Verfasst von Adishwar Rao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA (A.R.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Left Atrial Appendage Closure, Anticoagulants, Stroke. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Left atrial appendage closure (LAAC) is an alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation, but randomized controlled trials have primarily focused on composite end points, potentially obscuring differences in individual clinical outcomes. We compared the efficacy and safety of LAAC versus OAC with an emphasis on individual clinical outcomes. METHODS: A systematic review and meta-analysis of randomized controlled trials comparing LAAC with OAC in adults with atrial fibrillation was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Databases were searched from January 2000 to March 2026. The primary efficacy end point was any stroke, and the primary safety end point was major bleeding. Risk ratios (RRs) with 95% CIs were pooled using a random-effects model. RESULTS: Six randomized controlled trials comprising 7004 patients (3681 LAAC; 3323 OAC) were included. LAAC was associated with a higher risk of ischemic stroke (RR, 1.41 [95% CI, 1.04–1.91]; P =0.03; 3.2% versus 2.1%), without a significant difference in any stroke (RR, 1.08 [95% CI, 0.82–1.42]; P =0.60) or the composite of stroke, systemic embolism, or death (RR, 0.99 [95% CI, 0.77–1.29]; P =0.96). Cardiovascular mortality (RR, 0.88; P =0.40) and all-cause mortality (RR, 0.92; P =0.36) were similar between groups. Major bleeding, including procedural events, did not differ significantly (RR, 0.93; P =0.40), although LAAC was associated with a significantly lower risk of nonprocedural major bleeding (RR, 0.57 [95% CI, 0.43–0.77]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationLeft Atrial Appendage ClosureAnticoagulantsStrokeAtrial AppendageHumansRandomized Controlled Trials as TopicAdministration, OralTreatment OutcomeRisk FactorsRisk AssessmentFemaleHemorrhageMale

Stichwörter der Autor:innen

anticoagulantsatrial fibrillationhemorrhageischemic strokeleft atrial appendage closure

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA (A.R.).
  • Division of Electrophysiology, Heart and Vascular Institute, Saint Francis Health System, Tulsa, OK (V.R.).
  • Division of Cardiology, Cook County Health, Chicago, IL (M.M., A.V.).
  • Department of Internal Medicine, University of Texas Health Science Center at Tyler (R.C.).
  • Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, India (V.T.).
  • Jagadguru Jayadeva Murugarajendra Medical College, Davanagere, India (N.N.).

ORCID-Profile: Adishwar Rao, Venkatesh Ravi, Mukunthan Murthi, Rahul Chikatimalla, Vennela Talla, Nihal Nagaraj, Gaurav Dhar, Aviral Vij

Zitieren

APA

Rao, A., Ravi, V., Murthi, M., Chikatimalla, R., Talla, V., Nagaraj, N., Dhar, G., Jolly, N., & Vij, A. (2026). Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.126.015245

Vancouver

Rao A, Ravi V, Murthi M, Chikatimalla R, Talla V, Nagaraj N, et al. Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circulation: Arrhythmia and Electrophysiology. 2026. doi:10.1161/circep.126.015245

BibTeX
@article{Rao2026,
  author = {Rao, Adishwar and Ravi, Venkatesh and Murthi, Mukunthan and Chikatimalla, Rahul and Talla, Vennela and Nagaraj, Nihal and Dhar, Gaurav and Jolly, Neeraj and Vij, Aviral},
  title = {Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2026},
  doi = {10.1161/circep.126.015245}
}
Kostenlos starten →